ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liposome Assisted Drug Delivery Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-22Y5688
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Liposome Assisted Drug Delivery Market Insights Forecast to 2028
BUY CHAPTERS

Global Liposome Assisted Drug Delivery Market Insights, Forecast to 2030

Code: QYRE-Auto-22Y5688
Report
December 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang

Liposome Assisted Drug Delivery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Liposome Assisted Drug Delivery Market

Liposome Assisted Drug Delivery Market

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
Market Analysis and Insights: Global Liposome Assisted Drug Delivery Market
The global Liposome Assisted Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Liposome Assisted Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposome Assisted Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liposome Assisted Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposome Assisted Drug Delivery revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Liposome Assisted Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Liposome Assisted Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Liposome Assisted Drug Delivery Market Report

Report Metric Details
Report Name Liposome Assisted Drug Delivery Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau Group, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Liposome Assisted Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Liposome Assisted Drug Delivery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Assisted Drug Delivery revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Liposome Assisted Drug Delivery Market report?

Ans: The main players in the Liposome Assisted Drug Delivery Market are Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau Group, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang

What are the Application segmentation covered in the Liposome Assisted Drug Delivery Market report?

Ans: The Applications covered in the Liposome Assisted Drug Delivery Market report are Fungal Infection Therapy, Cancer & Tumor Therapy, Others

What are the Type segmentation covered in the Liposome Assisted Drug Delivery Market report?

Ans: The Types covered in the Liposome Assisted Drug Delivery Market report are Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others

Recommended Reports

Drug Delivery Systems

Cancer & Virus Therapy

Nanomedicine & Formulations

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Assisted Drug Delivery Market Perspective (2019-2030)
2.2 Global Liposome Assisted Drug Delivery Growth Trends by Region
2.2.1 Liposome Assisted Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liposome Assisted Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Liposome Assisted Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Liposome Assisted Drug Delivery Market Dynamics
2.3.1 Liposome Assisted Drug Delivery Industry Trends
2.3.2 Liposome Assisted Drug Delivery Market Drivers
2.3.3 Liposome Assisted Drug Delivery Market Challenges
2.3.4 Liposome Assisted Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Liposome Assisted Drug Delivery by Players
3.1.1 Global Liposome Assisted Drug Delivery Revenue by Players (2019-2024)
3.1.2 Global Liposome Assisted Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Liposome Assisted Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Liposome Assisted Drug Delivery, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Liposome Assisted Drug Delivery Market Concentration Ratio
3.4.1 Global Liposome Assisted Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposome Assisted Drug Delivery Revenue in 2023
3.5 Global Key Players of Liposome Assisted Drug Delivery Head office and Area Served
3.6 Global Key Players of Liposome Assisted Drug Delivery, Product and Application
3.7 Global Key Players of Liposome Assisted Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposome Assisted Drug Delivery Breakdown Data by Type
4.1 Global Liposome Assisted Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Liposome Assisted Drug Delivery Breakdown Data by Application
5.1 Global Liposome Assisted Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liposome Assisted Drug Delivery Market Size (2019-2030)
6.2 North America Liposome Assisted Drug Delivery Market Size by Type
6.2.1 North America Liposome Assisted Drug Delivery Market Size by Type (2019-2024)
6.2.2 North America Liposome Assisted Drug Delivery Market Size by Type (2025-2030)
6.2.3 North America Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
6.3 North America Liposome Assisted Drug Delivery Market Size by Application
6.3.1 North America Liposome Assisted Drug Delivery Market Size by Application (2019-2024)
6.3.2 North America Liposome Assisted Drug Delivery Market Size by Application (2025-2030)
6.3.3 North America Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
6.4 North America Liposome Assisted Drug Delivery Market Size by Country
6.4.1 North America Liposome Assisted Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Liposome Assisted Drug Delivery Market Size by Country (2019-2024)
6.4.3 North America Liposome Assisted Drug Delivery Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Liposome Assisted Drug Delivery Market Size (2019-2030)
7.2 Europe Liposome Assisted Drug Delivery Market Size by Type
7.2.1 Europe Liposome Assisted Drug Delivery Market Size by Type (2019-2024)
7.2.2 Europe Liposome Assisted Drug Delivery Market Size by Type (2025-2030)
7.2.3 Europe Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
7.3 Europe Liposome Assisted Drug Delivery Market Size by Application
7.3.1 Europe Liposome Assisted Drug Delivery Market Size by Application (2019-2024)
7.3.2 Europe Liposome Assisted Drug Delivery Market Size by Application (2025-2030)
7.3.3 Europe Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
7.4 Europe Liposome Assisted Drug Delivery Market Size by Country
7.4.1 Europe Liposome Assisted Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Liposome Assisted Drug Delivery Market Size by Country (2019-2024)
7.4.3 Europe Liposome Assisted Drug Delivery Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Liposome Assisted Drug Delivery Market Size (2019-2030)
8.2 China Liposome Assisted Drug Delivery Market Size by Type
8.2.1 China Liposome Assisted Drug Delivery Market Size by Type (2019-2024)
8.2.2 China Liposome Assisted Drug Delivery Market Size by Type (2025-2030)
8.2.3 China Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
8.3 China Liposome Assisted Drug Delivery Market Size by Application
8.3.1 China Liposome Assisted Drug Delivery Market Size by Application (2019-2024)
8.3.2 China Liposome Assisted Drug Delivery Market Size by Application (2025-2030)
8.3.3 China Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Liposome Assisted Drug Delivery Market Size (2019-2030)
9.2 Asia Liposome Assisted Drug Delivery Market Size by Type
9.2.1 Asia Liposome Assisted Drug Delivery Market Size by Type (2019-2024)
9.2.2 Asia Liposome Assisted Drug Delivery Market Size by Type (2025-2030)
9.2.3 Asia Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
9.3 Asia Liposome Assisted Drug Delivery Market Size by Application
9.3.1 Asia Liposome Assisted Drug Delivery Market Size by Application (2019-2024)
9.3.2 Asia Liposome Assisted Drug Delivery Market Size by Application (2025-2030)
9.3.3 Asia Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
9.4 Asia Liposome Assisted Drug Delivery Market Size by Region
9.4.1 Asia Liposome Assisted Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Liposome Assisted Drug Delivery Market Size by Region (2019-2024)
9.4.3 Asia Liposome Assisted Drug Delivery Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Liposome Assisted Drug Delivery Introduction
11.1.4 Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.1.5 Gilead Sciences Recent Developments
11.2 Pacira
11.2.1 Pacira Company Details
11.2.2 Pacira Business Overview
11.2.3 Pacira Liposome Assisted Drug Delivery Introduction
11.2.4 Pacira Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.2.5 Pacira Recent Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Details
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Introduction
11.3.4 Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.3.5 Sun Pharmaceutical Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Introduction
11.4.4 Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Company Details
11.5.2 Luye Pharma Business Overview
11.5.3 Luye Pharma Liposome Assisted Drug Delivery Introduction
11.5.4 Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.5.5 Luye Pharma Recent Developments
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Company Details
11.6.2 Sigma-Tau Group Business Overview
11.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Introduction
11.6.4 Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.6.5 Sigma-Tau Group Recent Developments
11.7 Ipsen (Onivyde)
11.7.1 Ipsen (Onivyde) Company Details
11.7.2 Ipsen (Onivyde) Business Overview
11.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Introduction
11.7.4 Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.7.5 Ipsen (Onivyde) Recent Developments
11.8 CSPC
11.8.1 CSPC Company Details
11.8.2 CSPC Business Overview
11.8.3 CSPC Liposome Assisted Drug Delivery Introduction
11.8.4 CSPC Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.8.5 CSPC Recent Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Introduction
11.9.4 Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.9.5 Teva Pharmaceutical Recent Developments
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Liposome Assisted Drug Delivery Introduction
11.10.4 Novartis Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.10.5 Novartis Recent Developments
11.11 Fudan-Zhangjiang
11.11.1 Fudan-Zhangjiang Company Details
11.11.2 Fudan-Zhangjiang Business Overview
11.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Introduction
11.11.4 Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2019-2024)
11.11.5 Fudan-Zhangjiang Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
List of Tables
    Table 1. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Liposomal Doxorubicin
    Table 3. Key Players of Liposomal Amphoteracin B
    Table 4. Key Players of Liposomal Paclitaxel
    Table 5. Key Players of Others
    Table 6. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Liposome Assisted Drug Delivery Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Liposome Assisted Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Liposome Assisted Drug Delivery Market Share by Region (2019-2024)
    Table 10. Global Liposome Assisted Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Liposome Assisted Drug Delivery Market Share by Region (2025-2030)
    Table 12. Liposome Assisted Drug Delivery Market Trends
    Table 13. Liposome Assisted Drug Delivery Market Drivers
    Table 14. Liposome Assisted Drug Delivery Market Challenges
    Table 15. Liposome Assisted Drug Delivery Market Restraints
    Table 16. Global Liposome Assisted Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Liposome Assisted Drug Delivery Revenue Share by Players (2019-2024)
    Table 18. Global Top Liposome Assisted Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Assisted Drug Delivery as of 2023)
    Table 19. Global Liposome Assisted Drug Delivery Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Liposome Assisted Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Liposome Assisted Drug Delivery, Headquarters and Area Served
    Table 22. Global Key Players of Liposome Assisted Drug Delivery, Product and Application
    Table 23. Global Key Players of Liposome Assisted Drug Delivery, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Liposome Assisted Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2019-2024)
    Table 27. Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2025-2030)
    Table 29. Global Liposome Assisted Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Liposome Assisted Drug Delivery Revenue Share by Application (2019-2024)
    Table 31. Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Liposome Assisted Drug Delivery Revenue Share by Application (2025-2030)
    Table 33. North America Liposome Assisted Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Liposome Assisted Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Liposome Assisted Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Liposome Assisted Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Liposome Assisted Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Liposome Assisted Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Liposome Assisted Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Liposome Assisted Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Liposome Assisted Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Liposome Assisted Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Liposome Assisted Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Liposome Assisted Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Liposome Assisted Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Liposome Assisted Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Liposome Assisted Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Liposome Assisted Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Liposome Assisted Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Liposome Assisted Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Liposome Assisted Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Liposome Assisted Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Liposome Assisted Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Liposome Assisted Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Liposome Assisted Drug Delivery Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Liposome Assisted Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Liposome Assisted Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Gilead Sciences Company Details
    Table 66. Gilead Sciences Business Overview
    Table 67. Gilead Sciences Liposome Assisted Drug Delivery Product
    Table 68. Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 69. Gilead Sciences Recent Developments
    Table 70. Pacira Company Details
    Table 71. Pacira Business Overview
    Table 72. Pacira Liposome Assisted Drug Delivery Product
    Table 73. Pacira Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 74. Pacira Recent Developments
    Table 75. Sun Pharmaceutical Company Details
    Table 76. Sun Pharmaceutical Business Overview
    Table 77. Sun Pharmaceutical Liposome Assisted Drug Delivery Product
    Table 78. Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 79. Sun Pharmaceutical Recent Developments
    Table 80. Johnson & Johnson Company Details
    Table 81. Johnson & Johnson Business Overview
    Table 82. Johnson & Johnson Liposome Assisted Drug Delivery Product
    Table 83. Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 84. Johnson & Johnson Recent Developments
    Table 85. Luye Pharma Company Details
    Table 86. Luye Pharma Business Overview
    Table 87. Luye Pharma Liposome Assisted Drug Delivery Product
    Table 88. Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 89. Luye Pharma Recent Developments
    Table 90. Sigma-Tau Group Company Details
    Table 91. Sigma-Tau Group Business Overview
    Table 92. Sigma-Tau Group Liposome Assisted Drug Delivery Product
    Table 93. Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 94. Sigma-Tau Group Recent Developments
    Table 95. Ipsen (Onivyde) Company Details
    Table 96. Ipsen (Onivyde) Business Overview
    Table 97. Ipsen (Onivyde) Liposome Assisted Drug Delivery Product
    Table 98. Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 99. Ipsen (Onivyde) Recent Developments
    Table 100. CSPC Company Details
    Table 101. CSPC Business Overview
    Table 102. CSPC Liposome Assisted Drug Delivery Product
    Table 103. CSPC Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 104. CSPC Recent Developments
    Table 105. Teva Pharmaceutical Company Details
    Table 106. Teva Pharmaceutical Business Overview
    Table 107. Teva Pharmaceutical Liposome Assisted Drug Delivery Product
    Table 108. Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 109. Teva Pharmaceutical Recent Developments
    Table 110. Novartis Company Details
    Table 111. Novartis Business Overview
    Table 112. Novartis Liposome Assisted Drug Delivery Product
    Table 113. Novartis Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 114. Novartis Recent Developments
    Table 115. Fudan-Zhangjiang Company Details
    Table 116. Fudan-Zhangjiang Business Overview
    Table 117. Fudan-Zhangjiang Liposome Assisted Drug Delivery Product
    Table 118. Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2019-2024) & (US$ Million)
    Table 119. Fudan-Zhangjiang Recent Developments
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Liposome Assisted Drug Delivery Market Share by Type: 2023 VS 2030
    Figure 3. Liposomal Doxorubicin Features
    Figure 4. Liposomal Amphoteracin B Features
    Figure 5. Liposomal Paclitaxel Features
    Figure 6. Others Features
    Figure 7. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Liposome Assisted Drug Delivery Market Share by Application: 2023 VS 2030
    Figure 9. Fungal Infection Therapy Case Studies
    Figure 10. Cancer & Tumor Therapy Case Studies
    Figure 11. Others Case Studies
    Figure 12. Liposome Assisted Drug Delivery Report Years Considered
    Figure 13. Global Liposome Assisted Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Liposome Assisted Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Liposome Assisted Drug Delivery Market Share by Region: 2023 VS 2030
    Figure 16. Global Liposome Assisted Drug Delivery Market Share by Players in 2023
    Figure 17. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Assisted Drug Delivery as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Liposome Assisted Drug Delivery Revenue in 2023
    Figure 19. North America Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
    Figure 21. North America Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
    Figure 22. North America Liposome Assisted Drug Delivery Market Share by Country (2019-2030)
    Figure 23. United States Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Liposome Assisted Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
    Figure 27. Europe Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
    Figure 28. Europe Liposome Assisted Drug Delivery Market Share by Country (2019-2030)
    Figure 29. Germany Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Liposome Assisted Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
    Figure 37. China Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
    Figure 38. Asia Liposome Assisted Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
    Figure 40. Asia Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
    Figure 41. Asia Liposome Assisted Drug Delivery Market Share by Region (2019-2030)
    Figure 42. Japan Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Liposome Assisted Drug Delivery Market Share by Country (2019-2030)
    Figure 52. Brazil Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Liposome Assisted Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Gilead Sciences Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 59. Pacira Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 60. Sun Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 61. Johnson & Johnson Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 62. Luye Pharma Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 63. Sigma-Tau Group Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 64. Ipsen (Onivyde) Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 65. CSPC Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 66. Teva Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 67. Novartis Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 68. Fudan-Zhangjiang Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Liposome Drug Delivery Market Insights Forecast to 2030
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030
Global Microsphere Liposomes Market Research Report 2024
Global Liposomal Market Insights Forecast to 2030
Global Liposome Development Service Market Research Report 2025
Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030
Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Delivery in Cancer Market Insights Forecast to 2030
Global Pharmaceutics and Novel Drug Delivery Systems Market Insights Forecast to 2030
Global Leishmaniasis Treatment Market Insights Forecast to 2030
Global Lipid Microsphere Formulation Market Research Report 2024
Global Liposomal Supplements Market Research Report 2025
Liposomal Amikacin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions